The management of nursing scheduling in healthcare facilities have faced new challenges during the COVID-19 pandemic. With the rapid development of big data and artificial intelligence technology, data-driven intelligent medical services are what we need to study nowadays. This paper not only proposes reasonable solutions in areas such as refined nursing scheduling by using these scientific technologies to quickly realize the allocation of human resources in hospitals. It also accelerates the development of hospital informatization construction through computer technology, establishing a scientific and intelligent medical platform that meets the needs of users. Aiming at the problem of nursing scheduling in medical service data research, this paper proposes a complete plan by analyzing the development of the medical platform at this stage. Firstly, established an intelligent medical service platform, and studied the medical management from the perspective of data. Then, analyze the intelligent medical platform data by utilizing optimized algorithms, through reasonable analysis under various constraints, to get the basic nursing scheduling plan that meets the needs of medical institutions. Finally, considering the actual situation of emergency medical treatment, the decision classification model is introduced under the basic scheme to further screen out the optimal management scheme of modern medical treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484945 | PMC |
http://dx.doi.org/10.1155/2022/3293806 | DOI Listing |
BMC Cancer
January 2025
Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.
Background: Hematopoietic stem cell transplantation (HSCT) is a common therapy for many hematologic malignancies. While advances in transplant practice have improved cancer-specific outcomes, multiple and debilitating long term physical and psychologic effects remain. Patients undergoing allogeneic bone marrow transplantation (allo-BMT) are often critically ill at initial diagnosis and with necessary sequential treatments become increasingly frail and deconditioned.
View Article and Find Full Text PDFNat Med
January 2025
Centre for Healthy Brain Ageing (CHeBA), School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55-77 years with modifiable dementia risk factors.
View Article and Find Full Text PDFJ Adv Nurs
January 2025
Department of Pediatrics, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Objective: To systematically evaluate the effect of cue-based feeding (CBF) on feeding outcomes in preterm infants.
Methods: Databases including CNKI, Wanfang, PubMed, Embase, CINAHL and Cochrane Library were searched from the database's inception to November 2023. The literature screening and quality assessment were conducted by two researchers independently, and a meta-analysis was performed using Review Manager (RevMan) 5.
J Dr Nurs Pract
January 2025
University of South Alabama College of Nursing, Mobile, AL, USA
Surgical delays can lead to patient dissatisfaction and negatively affect hospital revenue. Maximizing operating room (OR) efficiencies is a high priority. A common metric for OR efficiency is first-case on-time start (FCOTS).
View Article and Find Full Text PDFBirth Defects Res
February 2025
Translational Research Division, Chugai Pharmaceutical Co. Ltd., Chuo, Japan.
Background: Nemolizumab, a humanized monoclonal antibody against interleukin-31 receptor A (IL-31RA), is used to treat atopic dermatitis and prurigo nodularis. These inflammatory skin diseases affect a wide range of age groups, including pregnant women and children; however, little is known about their biological effects on pre- and postnatal development. Therefore, we report and discuss the results of an enhanced pre- and postnatal development study in cynomolgus monkeys treated with nemolizumab, which also incorporates an assessment of juvenile toxicities.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!